GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » EPS (Diluted)

CellSource Co (TSE:4880) EPS (Diluted) : 円43.92 (TTM As of Jan. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CellSource Co EPS (Diluted)?

CellSource Co's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was 円7.23. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was 円43.92.

CellSource Co's EPS (Basic) for the three months ended in Jan. 2024 was 円7.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was 円44.59.

CellSource Co's EPS without NRI for the three months ended in Jan. 2024 was 円6.98. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was 円42.55.

During the past 12 months, CellSource Co's average EPS without NRIGrowth Rate was -24.50% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 47.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 34.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, CellSource Co's highest 3-Year average EPS without NRI Growth Rate was 51.70% per year. The lowest was 30.50% per year. And the median was 39.80% per year.


CellSource Co EPS (Diluted) Historical Data

The historical data trend for CellSource Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co EPS (Diluted) Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EPS (Diluted)
Get a 7-Day Free Trial 15.29 14.33 33.91 52.98 47.93

CellSource Co Quarterly Data
Oct18 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.24 10.10 13.80 12.79 7.23

Competitive Comparison of CellSource Co's EPS (Diluted)

For the Biotechnology subindustry, CellSource Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSource Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSource Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where CellSource Co's PE Ratio falls into.



CellSource Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

CellSource Co's Diluted EPS for the fiscal year that ended in Oct. 2023 is calculated as

Diluted EPS (A: Oct. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(923.142-0)/19.260
=47.93

CellSource Co's Diluted EPS for the quarter that ended in Jan. 2024 is calculated as

Diluted EPS (Q: Jan. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(143.901-0)/19.903
=7.23

EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円43.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellSource Co  (TSE:4880) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


CellSource Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of CellSource Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


CellSource Co (TSE:4880) Business Description

Traded in Other Exchanges
N/A
Address
Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines